These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2121485)

  • 21. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway.
    Katsura M; Forster LA; Ferns GA; Anggård EE
    Biochim Biophys Acta; 1994 Jul; 1213(2):231-7. PubMed ID: 8025135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M; Leake DS; Rice-Evans CA
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oxidative modification of low-density lipoproteins by macrophages.
    Leake DS; Rankin SM
    Biochem J; 1990 Sep; 270(3):741-8. PubMed ID: 2122885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.
    Podrez EA; Schmitt D; Hoff HF; Hazen SL
    J Clin Invest; 1999 Jun; 103(11):1547-60. PubMed ID: 10359564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical increase in LDL oxidation by endothelial cells from an atherosclerosis-resistant mouse strain.
    Miyoshi T; Matsumoto AH; Shi W
    Atherosclerosis; 2007 Jun; 192(2):259-65. PubMed ID: 16919636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor.
    Parthasarathy S; Fong LG; Otero D; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):537-40. PubMed ID: 3467373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probucol inhibits oxidative modification of low density lipoprotein.
    Parthasarathy S; Young SG; Witztum JL; Pittman RC; Steinberg D
    J Clin Invest; 1986 Feb; 77(2):641-4. PubMed ID: 3944273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid.
    Mangiapane H; Thomson J; Salter A; Brown S; Bell GD; White DA
    Biochem Pharmacol; 1992 Feb; 43(3):445-50. PubMed ID: 1540202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions.
    Ylä-Herttuala S; Rosenfeld ME; Parthasarathy S; Glass CK; Sigal E; Witztum JL; Steinberg D
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):6959-63. PubMed ID: 1698286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfer of lipoproteins from plasma to the cell populations of the normal and atherosclerotic arterial tissue.
    Bondjers G; Wiklund O; Fager G; Camejo EH; Camejo G
    Eur Heart J; 1990 Aug; 11 Suppl E():158-63. PubMed ID: 2226524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-amyloid (Abeta40, Abeta42) binding to modified LDL accelerates macrophage foam cell formation.
    Schulz B; Liebisch G; Grandl M; Werner T; Barlage S; Schmitz G
    Biochim Biophys Acta; 2007 Oct; 1771(10):1335-44. PubMed ID: 17881287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
    Yuan XM; Anders WL; Olsson AG; Brunk UT
    Atherosclerosis; 1996 Jul; 124(1):61-73. PubMed ID: 8800494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
    Heinecke JW; Baker L; Rosen H; Chait A
    J Clin Invest; 1986 Mar; 77(3):757-61. PubMed ID: 3005364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Lipoxygenase is not essential in macrophage-mediated oxidation of low-density lipoprotein.
    Jessup W; Darley-Usmar V; O'Leary V; Bedwell S
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):163-9. PubMed ID: 1883327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The possible role of copper ions in atherogenesis: the Blue Janus.
    Ferns GA; Lamb DJ; Taylor A
    Atherosclerosis; 1997 Sep; 133(2):139-52. PubMed ID: 9298674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of superoxide in endothelial-cell modification of low-density lipoproteins.
    Steinbrecher UP
    Biochim Biophys Acta; 1988 Mar; 959(1):20-30. PubMed ID: 2830901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.
    Ylä-Herttuala S; Rosenfeld ME; Parthasarathy S; Sigal E; Särkioja T; Witztum JL; Steinberg D
    J Clin Invest; 1991 Apr; 87(4):1146-52. PubMed ID: 2010531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.